Cadila Healthcare receives USFDA nod to market Nifedipine tablets
Cadila Healthcare has received final approval to market Nifedipine extended-release tablets USP in the strengths of 30 mg, 60 mg, and 90 mg, from the US...
Use UNICORN Signals App
By EquityPandit
